Your AI-Trained Oncology Knowledge Connection!

Optimizing Treatment Strategies for HR+/HER2- Breast Cancer: ESR1 Mutations and Emerging Therapies : Episode 10

Opinion

Video

July 22, 2024

Combinations and Treatment Sequence Strategies in Breast Cancer

Author(s):

Virginia G. Kaklamani, MD, DSc,Heather McArthur, MD, MPH

In their discussion, the key opinion leaders explore the potential of combination therapies in HR+/HER2- metastatic breast cancer, with a specific focus on the ELECTRA study, which investigated the combination of elacestrant and abemaciclib.

EP: 1.Prevalence and Testing Strategies for ESR1

EP: 2.Evolution of Testing Strategies for ESR1

EP: 3.Dynamics of ESR1 Alterations and Serial Liquid Biopsies

EP: 4.Case Presentation 1: PIK3CA Mutation With ESR1 Mutations

EP: 5.EMERALD Study Design and Results for Elacestrant

EP: 6.Evolving Best Practices for ESR1 Testing

EP: 7.Case Presentation 2: Co-mutations in ESR1 and PIK3CA

EP: 8.PIK3CA Mutations and Delivering PI3K Inhibitors

EP: 9.PostMONARCH: Dissecting Data on Sequential CDK 4/6 Inhibitors

Now Viewing

EP: 10.Combinations and Treatment Sequence Strategies in Breast Cancer

EP: 11.Future Directions and Unmet Needs in HR+ Breast Cancer

EP: 12.Looking Ahead: Expert Future Perspectives in HR+ Breast Cancer

ELECTRA (Elacestrant + abemaciclib)

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 18th 2025 - Apr 19th 2026

online-activity

Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity

Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity

Latest Conference Coverage

Overview of iMMagine-1 Trial: Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of R/R MM

Application of Real-World Evidence in Selecting CAR T in R/R MM

Addition of Daratumumab to Lenalidomide Maintenance Boosts MRD-Negative Conversions in Myeloma Following ASCT

Apalutamide Boosts 24-Month OS in Real-World Population With Metastatic Castration-Sensitive Prostate Cancer

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

Combinations and Treatment Sequence Strategies in Breast Cancer

EP: 1.Prevalence and Testing Strategies for ESR1

EP: 2.Evolution of Testing Strategies for ESR1

EP: 3.Dynamics of ESR1 Alterations and Serial Liquid Biopsies

EP: 4.Case Presentation 1: PIK3CA Mutation With ESR1 Mutations

EP: 5.EMERALD Study Design and Results for Elacestrant

EP: 6.Evolving Best Practices for ESR1 Testing

EP: 7.Case Presentation 2: Co-mutations in ESR1 and PIK3CA

EP: 8.PIK3CA Mutations and Delivering PI3K Inhibitors

EP: 9.PostMONARCH: Dissecting Data on Sequential CDK 4/6 Inhibitors

EP: 10.Combinations and Treatment Sequence Strategies in Breast Cancer

EP: 11.Future Directions and Unmet Needs in HR+ Breast Cancer

EP: 12.Looking Ahead: Expert Future Perspectives in HR+ Breast Cancer

Newsletter

Latest CME

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Addressing Unmet Needs in HER2+ Metastatic BTC

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Addressing Unmet Needs in HER2+ Metastatic BTC

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Latest Conference Coverage